Becker's Hospital Review

October 2019 Becker's Hospital Review

Issue link: https://beckershealthcare.uberflip.com/i/1169964

Contents of this Issue

Navigation

Page 52 of 119

53 Dave Chokshi, MD. Chief Population Health Officer at NYC Health + Hospitals and CEO of NYC Health + Hospitals ACO (New York City). Dr. Chokshi is the chief population health officer of and CEO of the ACO at NYC Health + Hospitals, the largest public healthcare sys- tem in the nation with 11 hospitals and more than 70 care locations. He is responsible for health system improvement, ambulatory care trans- formation, care model design and implementation, population health analytics, and chronic disease prevention. Prior to taking on his cur- rent role, Dr. Chokshi was the assistant vice president of ambulatory care transformation at NYC Health + Hospitals, director of population health improvement at NYU Langone Health, and a White House fellow at the U.S. Department of Veterans Affairs. He has published in several medical journals and serves on the board of directors of the Primary Care Development Corp. and the Essential Hospitals Institute. Reginald Coopwood, MD. President and CEO of Regional One Health (Memphis, Tenn.). Dr. Coopwood assumed the role as president and CEO of Regional One Health in 2010. Dr. Coopwood previously served as CEO of the Metropolitan Nashville (Tenn.) Hospital Authority. Additionally, he is the Memphis division board chair for the March of Dimes and a board member with the state chapter of the organization. He serves as speaker of the Tennessee Hospital Association House of Delegates and chair of the MidSouth e-Health Alliance board, and is a member of the board of Blue Cross Blue Shield Tennessee. Norvell Coots, MD. President and CEO of Holy Cross Health (Sil- ver Spring, Md.). Dr. Coots is the president and CEO of Holy Cross Health, a nonprofit Catholic health system with 4,100 employees who serve more than 240,000 patients annually. He assumed the role in 2016, aer serving in the U.S. Army as the former commanding gener- al and CEO of Regional Health Command Europe. Dr. Coots has more than 20 years of experience in healthcare management and medical administration. In September 2018, he was one of 14 executive leaders to receive the Distinguished Healthcare Leader Award from the Na- tional Association of Health Services Executives for his dedication to healthcare in his community. Steven Corwin, MD. President and CEO of NewYork-Presbyterian (New York City). Under the leadership of Dr. Corwin, NewYork-Pres- byterian has doubled in size and now includes more than 47,000 em- ployees who serve 4 million patients at 200 practices and clinics across the greater New York City area. As president and CEO, Dr. Corwin en- courages high-quality, patient-centered care and clinical excellence, as well as pioneering research and medical student education. Dr. Corwin led the creation of the NewYork-Presbyterian Regional Network and NewYork-Presbyterian Medical Groups. He launched the NYP OnDe- mand initiative and the Respect initiative, which focuses on employee teamwork. Before becoming CEO, he served as NewYork-Presbyterian Hospital's executive vice president and COO. Dr. Corwin is the immedi- ate past chairman of the health systems council of the American Hospi- tal Association and is a member of numerous boards. Kenneth Davis, MD. President and CEO of Mount Sinai Health Sys- tem (New York City). As president and CEO of Mount Sinai Health System, an eight-hospital health system, Dr. Davis has made many im- provements in finances and education. He previously served as dean of Mount Sinai School of Medicine. Additionally, Dr. Davis has made lasting contributions to the field with his Alzheimer's disease research, which led to FDA approval of three of the first four drugs approved for Alzheimer's. He has been honored by the American Psychiatric Asso- ciation, and Yale University presented him with the George H.W. Bush '48 Lifetime of Leadership Award. Ralph de la Torre, MD. Chairman and CEO of Steward Health Care System (Dallas). Dr. de la Torre is the chairman, founder and CEO of Steward Health Care System, a large private hospital operator with 37 community hospitals. e health system is based on a model that keeps patients healthy and close to home. He previously served as CEO of Boston-based Caritas Christi Health Care, where he made many large scale transformations. Dr. de la Torre was also the founder and CEO of the Cardiovascular Institute of Beth Israel Deaconess Medical Center in Boston and of Cardiovascular Management Associates, one of the first completely integrated systems for treating cardiac patients in the U.S. James Downing, MD. President and CEO of St. Jude Children's Re- search Hospital (Memphis, Tenn.). Since assuming the role of presi- dent and CEO of St. Jude Children's Research Hospital, a leading child cancer treatment facility, Dr. Downing has developed a six-year plan that aims to expand the organization's clinical care and research pro- grams. His research studies the genetic basis of cancer to treat sick chil- dren. Dr. Downing launched the Pediatric Cancer Genome Project and was a finalist for TIME magazine's list of 100 most influential people in the world. Most recently, he was awarded the 2018 Society of Memorial Sloan Kettering Prize and the 2019 Pediatric Oncology Award and Lec- ture from the American Society of Clinical Oncology. Susan Ehrlich, MD. CEO of Zuckerberg San Francisco General Hos- pital and Trauma Center. Dr. Ehrlich is the CEO of Zuckerberg San Francisco General, a 397-bed hospital with a faculty of 5,400 members and a budget of $1.1 billion. She has a strong background in medicine and public health. Previously, Dr. Ehrlich worked at San Mateo (Calif.) Medical Center for 14 years, where she served as CEO, CMO and vice president. She also served as the founding medical director of the Ron Robinson Senior Care Center in San Mateo. Darryl Elmouchi, MD. CMO of Spectrum Health and President of Spectrum Health Medical Group (Grand Rapids, Mich.). Dr. Elmou- chi assumed the role of CMO of Spectrum Health, a Michigan-based system with 4,200-plus physicians, in 2017. He continues to practice as a cardiologist. Prior to becoming president, Dr. Elmouchi served as chief of the division of cardiovascular medicine at Spectrum Health Medical Group and department chair of cardiovascular medicine. He is also an assistant professor of medicine at Michigan State University College of Human Medicine in East Lansing. Melinda Estes, MD. President and CEO of Saint Luke's Health Sys- tem (Kansas City, Mo.). As president and CEO of Saint Luke's Health System, Dr. Estes oversees operations across 18 hospital campuses, and 100 physician practices and clinics. Before joining Saint Luke's, Dr. Es- tes served as president and CEO of Burlington, Vt.-based Fletcher Al- len Health Care — now known as the University of Vermont Medical Center — and CMO and CEO of Cleveland Clinic Florida in Weston. She was also a practicing neurologist and neuropathologist. Dr. Estes serves on the board and executive committee of the American Hospital Association. In 2018, the AHA board of trustees named her chair-elect designate, meaning she will assume the highest elected position the AHA in 2020. Julie Ann Freischlag, MD. CEO of Wake Forest Baptist Health and Dean of Wake Forest School of Medicine. (Winston-Salem, N.C.). Dr. Freischlag oversees all the clinical, academic and innovation enterprises of Wake Forest Baptist and manages the system's annual operating bud- get of $2.5 billion. She is also dean of Wake Forest School of Medicine. Dr. Freischlag has been active in creating change in medical education through emphasizing diversity and inclusion. Previously, she served as vice chancellor for human health sciences and dean of the School of Medicine at UC Davis. Dr. Freischlag has published more than 250 manuscripts, abstracts and book chapters. She is nationally known for treating thoracic outlet syndrome. Dr. Freischlag serves on the executive board of the Association of Academic Health Centers, the Karachi, Pa- kistan-based Aga Khan University board of trustees and the University of Pittsburgh School of Medicine advisory board.

Articles in this issue

view archives of Becker's Hospital Review - October 2019 Becker's Hospital Review